Methylglyoxal further impairs adipose tissue metabolism after partial decrease of blood supply

References

• Akhand A, Hossain K, Mitsui H, et al. (2001). Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells. Free Rad Biol Med, 31:20–30
   PubMed Web of Science ®Google Scholar
• Balistreri C, Caruso C, Candore G. (2010). The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Med Inflam, 10:1–19
   Google Scholar
• Bento C, Marques F, Fernandes R, Pereira P. (2010a). Methylglyoxal alters the function and stability of critical components of the protein quality control. PLoS ONE, 5:e13007
   PubMedGoogle Scholar
• Bento CF, Fernandes R, Matafome P, et al. (2010b). Methylglyoxal-induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction. Exp Physiol, 95:955–70
   PubMed Web of Science ®Google Scholar
• Berggreen C, Gormand A, Omar B, et al. (2009). Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. Am J Physiol Endo Metab, 296:E635–46
   PubMed Web of Science ®Google Scholar
• Brownlee M. (2005). The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 54:1615–25
   PubMed Web of Science ®Google Scholar
• Catarino S, Bento CF, Brito A, et al. (2012). Regulation of the expression of interleukin-8 induced by 25-hydroxycholesterol in retinal pigment epithelium cells. Acta Ophthal, 90:e255–63
   PubMed Web of Science ®Google Scholar
• Chaiban JT, Bitar FF, Azar ST. (2008). Effect of chronic hypoxia on leptin, insulin, adiponectin, and ghrelin. Metab: Clin Exp, 57:1019–22
   PubMed Web of Science ®Google Scholar
• Chan W-H, Wu H-J, Shiao N-H. (2007). Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2. J Cell Biochem, 100:1056–69
   PubMed Web of Science ®Google Scholar
• Chen B, Lam KSL, Wang Y, et al. (2006). Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Comm, 341:549–56
   PubMed Web of Science ®Google Scholar
• Cònsol G, Moles A, Ricart-Jané D, Llobera M. (2005). An in situ perfusion protocol of rat epididymal adipose tissue useful in metabolic studies. J Lipid Res, 46:1803–8
   PubMed Web of Science ®Google Scholar
• Gaens KHJ, Ferreira I, Kallen CJH, et al. (2009). Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. J Clin Endocrin Metab, 94:5174–80
   PubMed Web of Science ®Google Scholar
• Galic S, Oakhill JS, Steinberg GR. (2010). Adipose tissue as an endocrine organ. Mol Cell Endocrin, 316:129–39
   PubMed Web of Science ®Google Scholar
• Goldin A, Beckman J, Schmidt AM, Creager M. (2006). Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation, 114:597–605
   PubMed Web of Science ®Google Scholar
• Guilherme A, Virbasius JV, Puri V, Czech MP. (2008). Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature Reviews. Mol Cell Biol, 9:367–77
   Google Scholar
• Hirasawa Y, Sakai T, Ito M, et al. (2011). Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway. Euro J Pharma, 672:159–68
   PubMed Web of Science ®Google Scholar
• Hosogai N, Fukuhara A, Oshima K, et al. (2007). Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes, 56:901–11
   PubMed Web of Science ®Google Scholar
• Juge-Aubry CE, Henrichot E, Meier C. (2005). Adipose tissue: a regulator of inflammation. Best Practice Res Clin Endocrin Metab, 19:547–66
   PubMed Web of Science ®Google Scholar
• Kim K, Song MJ, Chung J, et al. (2005). Hypoxia inhibits adipocyte differentiation in a HDAC-independent manner. Biochem Biophys Res Comm, 333:1178–84
   PubMed Web of Science ®Google Scholar
• Koka V, Wang W, Huang XR, et al. (2006). Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications. Circulation, 113:1353–60
   PubMed Web of Science ®Google Scholar
• Mannerås-Holm L, Krook A. (2012). Targeting adipose tissue angiogenesis to enhance insulin sensitivity. Diabetologia, 55:2562–4
   PubMed Web of Science ®Google Scholar
• Matafome P, Santos-Silva D, Crisóstomo J, et al. (2012). Methylglyoxal causes structural and functional alterations in adipose tissue independently of obesity. Arch Physiol Biochem, 118:58–68
   PubMed Web of Science ®Google Scholar
• Matafome P, Sena C, Seiça R. (2013). Methylglyoxal, obesity, and diabetes. Endocrine, 43(3):472--84
   Google Scholar
• Maury E, Brichard SM. (2010). Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrin, 314:1–16
   PubMed Web of Science ®Google Scholar
• Negre-Salvayre A, Salvayre R, Augé N, et al. (2009). Hyperglycemia and glycation in diabetic complications. Antioxidants & Redox Sig, 11:3071–109
   PubMed Web of Science ®Google Scholar
• Nunn AV, Bell J, Barter P. (2007). The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance. Nuclear Receptor, 5:1–13
   PubMedGoogle Scholar
• Omar B, Zmuda-Trzebiatowska E, Manganiello V, et al. (2009). Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis. Cellular Sig, 21:760–6
   PubMed Web of Science ®Google Scholar
• Rabbani N, Thornalley PJ. (2012). Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids, 42:1133–42
   PubMed Web of Science ®Google Scholar
• Rajala MW, Scherer PE. (2003). Minireview: The adipocyte – at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology, 144:3765–73
   PubMed Web of Science ®Google Scholar
• Regazzetti C, Peraldi P, Grémeaux T, et al. (2009). Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes, 58:95–103
   PubMed Web of Science ®Google Scholar
• Rodrigues T, Paulo M, Santos-Silva D, et al. (2013). Reduction of methylglyoxal-induced glycation by pyridoxamine improves adipose tissue microvascular lesions. J Diabetes Res, 2013; 690650
   Google Scholar
• Rutkowski JM, Davis KE, Scherer PE. (2009). Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue. FEBS J, 276:5738–46
   PubMed Web of Science ®Google Scholar
• Sena C, Matafome P, Crisóstomo J, et al. (2012). Methylglyoxal promotes oxidative stress and endothelial dysfunction. Pharma Res: Official J Italian Pharm Soc, 65:497–506
   Google Scholar
• Strissel K, Stancheva Z, Miyoshi H. (2007). Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes, 56:2910–18
   PubMed Web of Science ®Google Scholar
• Trayhurn P, Wang B, Wood IS. (2008). Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Brit J Nutrition, 100:227–35
   PubMed Web of Science ®Google Scholar
• Trayhurn P, Wood IS. (2004). Adipokines: inflammation and the pleiotropic role of white adipose tissue. Brit J Nutrition, 92:347--355
   PubMed Web of Science ®Google Scholar
• Vázquez-Vela MEF, Torres N, Tovar AR. (2008). White adipose tissue as endocrine organ and its role in obesity. Arch Med Res, 39:715–28
   PubMed Web of Science ®Google Scholar
• Ye J. (2010). Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obesity, 33:235–47
   Google Scholar
• Ye J, Gao Z, Yin J, He Q. (2007). Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J PhysiolEndocrin Metab, 293:E1118–28
   PubMed Web of Science ®Google Scholar